Skip to content Provide accessibility feedback
For Providers
For Patients
Customer Stories
About Us
Contact Us
Magnifying glass Search

Volpara has entered into a Scheme Implementation Agreement with Lunit, Inc.

Unique insight for early detection of breast cancer

Every woman is different, with unique breast composition and sensitivity to breast screening. Our breast health software combines science and artificial intelligence to deliver personalized breast screening for each woman.

1
Breast cancer risk insight

We empower physicians and patients with a complete breast cancer risk assessment program, including integrated Tyrer-Cuzick modeling.

2
Precise breast density

The only volumetric breast density scale validated for use with the Tyrer-Cuzick breast cancer risk calculator.

3
Personal care pathways

Triage high-risk women to additional breast screening and genetic testing as needed.

3 m+

Breast cancer risk assessments annually

14.5 m+

Women across 40 countries have had their breast density assessed by Volpara Health

The only

Volumetric breast density assessment validated for use with Tyrer-Cuzick 8

Breast health software

AI-powered software to optimize breast imaging

Volpara Scorecard

Scorecard

View patient risk insights essential for early detection.

Volpara Patient Hub

Patient Hub

Speed your workflow with customizable patient reporting and communications.

Volpara Risk

Risk Pathways

A full program for identifying, tracking, and managing high-risk patients.

Explore

You might be interested in...

Blog
25 Jan 2022

Lung cancer screening and early detection is vital for high-risk patients

Blog
assessing breast cancer risk
3 May 2021

Rise in breast cancer in women under 40 calls for shift to early risk assessment